慢性阻塞性肺疾病的中西医治疗研究进展
Progress in Traditional Chinese and Western Medicine Treatment of Chronic Obstructive Pulmonary Disease
DOI: 10.12677/tcm.2025.143157, PDF,   
作者: 陈柯蓉:广西中医药大学瑞康临床医学院,广西 南宁;梁 炜:广西中医药大学附属瑞康医院呼吸与危重症医学科,广西 南宁
关键词: 慢性阻塞性肺疾病中西医结合研究进展文献综述Chronic Obstructive Pulmonary Disease Integrated Traditional Chinese and Western Medicine Research Progress Journals Reviewed
摘要: 目的:总结慢性阻塞性肺疾病(COPD)的中西医研究进展。方法:通过收集、整理近年来COPD的相关文献进行归纳、总结以及分析。结果:西医常规治疗COPD主要采用支气管扩张剂、糖皮质激素,减轻临床症状。对COPD的中医药治疗应依据其病因病机,强调整体观念及辨证论治,多采用补肺益肾健脾、化痰祛瘀等治法,副作用小有优势。结论:中西医结合治疗COPD,能够发挥各自优势,减轻患者症状,提高生活质量,值得进一步研究和推广。未来的研究方向应更加注重中西医结合治疗COPD的机制探讨,以及更加精准、个体化的治疗方案制定。
Abstract: Objective: To summarize the research progress of traditional Chinese and Western medicine in chronic obstructive pulmonary disease (COPD). Method: Summarize and analyze relevant literature on COPD in recent years by collecting and organizing them. Result: Conventional Western medicine treatment for COPD mainly uses bronchodilators and glucocorticoids to alleviate clinical symptoms. The traditional Chinese medicine treatment of COPD should be based on its etiology and pathogenesis, emphasizing a holistic approach and syndrome differentiation. Treatment methods such as tonifying the lungs, benefiting the kidneys, strengthening the spleen, resolving phlegm, and removing blood stasis are often used, which have the advantage of minimal side effects. Conclusion: The combination of traditional Chinese and Western medicine in the treatment of COPD can leverage their respective advantages, alleviate patients’ symptoms, and improve their quality of life, which is worthy of further research and promotion. Future research directions should focus more on exploring the mechanisms of integrated traditional Chinese and Western medicine in treating COPD, as well as developing more precise and personalized treatment plans.
文章引用:陈柯蓉, 梁炜. 慢性阻塞性肺疾病的中西医治疗研究进展[J]. 中医学, 2025, 14(3): 1037-1041. https://doi.org/10.12677/tcm.2025.143157

参考文献

[1] 荣健, 戈艳红, 陈贵梅, 等. 2010-2019年中国40岁及以上成人慢性阻塞性肺疾病患病率的Meta分析[J]. 现代预防学, 2020, 47(13): 2305-2309, 2336.
[2] 李阳, 任炼. 1990-2021年中国、日本、韩国慢性阻塞性肺疾病负担与变化趋势分析[J]. 中国循证心血管医学杂志, 2024, 16(11): 1289-1294.
[3] Global Initiative for Chronic Obstructive Lung Disease (2020) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2020 Report).
[4] Brandsma, C., Van den Berge, M., Hackett, T., Brusselle, G. and Timens, W. (2019) Recent Advances in Chronic Obstructive Pulmonary Disease Pathogenesis: From Disease Mechanisms to Precision Medicine. The Journal of Pathology, 250, 624-635. [Google Scholar] [CrossRef] [PubMed]
[5] Vogelmeier, C.F., Román-Rodríguez, M., Singh, D., Han, M.K., Rodríguez-Roisin, R. and Ferguson, G.T. (2020) Goals of COPD Treatment: Focus on Symptoms and Exacerbations. Respiratory Medicine, 166, Article 105938. [Google Scholar] [CrossRef] [PubMed]
[6] Ribeiro Baptista, B., Valentin, S., Chaouat, A. and Chabot, F. (2024) Histoire Naturelle de la BPCO: Évolution des concepts. Revue du Praticien, 74, 194-198.
[7] Papi, A., Vestbo, J., Fabbri, L., Corradi, M., Prunier, H., Cohuet, G., et al. (2018) Extrafine Inhaled Triple Therapy versus Dual Bronchodilator Therapy in Chronic Obstructive Pulmonary Disease (TRIBUTE): A Double-Blind, Parallel Group, Randomised Controlled Trial. The Lancet, 391, 1076-1084. [Google Scholar] [CrossRef] [PubMed]
[8] Herath, S.C., Normansell, R., Maisey, S. and Poole, P. (2018) Prophylactic Antibiotic Therapy for Chronic Obstructive Pulmonary Disease (COPD). Cochrane Database of Systematic Reviews, No. 10, CD009764. [Google Scholar] [CrossRef] [PubMed]
[9] Anthonisen, N.R., Skeans, M.A., Wise, R.A., Manfreda, J., Kanner, R.E. and Connett, J.E. (2005) The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality. Annals of Internal Medicine, 142, 233-239. [Google Scholar] [CrossRef] [PubMed]
[10] 洪利兴, 王圣楠, 郭伟峰, 等. 肺康复治疗应用于慢阻肺缓解期患者的临床治疗效果分析[J]. 中外医疗, 2024, 43(3): 71-74.
[11] The Long-Term Oxygen Treatment Trial Research Group (2016) A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. New England Journal of Medicine, 375, 1617-1627. [Google Scholar] [CrossRef] [PubMed]
[12] 谢香婷, 严秋凤. 慢性阻塞性肺疾病急性加重期并发下呼吸道感染患者病原菌分布特点及耐药情况分析[J]. 黑龙江医学, 2024, 48(18): 2236-2238.
[13] 李军胜, 郭艳华. 慢性阻塞性肺疾病急性加重期全身应用糖皮质激素治疗的疗效观察[J]. 北方药学, 2016, 13(1): 77.
[14] 陈青青, 杨美菊, 郭玉, 等. 纤支镜肺泡灌洗治疗慢阻肺急性加重并呼吸衰竭的临床疗效分析[J]. 罕少疾病杂志, 2024, 31(12): 51-53.
[15] 周莉娟, 周丽, 顾倩. 经鼻高流量氧疗在AECOPD患者中的应用价值[J]. 吉林医学, 2024, 45(12): 3151-3154.
[16] 杨建兰, 王昕慧, 沈燕, 等. 基于eCASH理念的肺康复训练在AECOPD合并Ⅱ型呼吸衰竭患者中的应用[J]. 护理实践与研究, 2024, 21(11): 1694-1699.
[17] 李冀. 张常喜主任基于虚-痰-瘀理论治疗慢性阻塞性肺疾病的初探[J]. 中华养生保健, 2024, 42(23): 72-75.
[18] 周忠辉, 徐俪颖. 王会仍运用肺心同治法治疗肺胀经验[J]. 浙江中西医结合杂志, 2024, 34(11): 984-986.
[19] 李明非, 焦旭, 卢云. 卢云教授从通至邪出辨痰论治肺胀的经验[J]. 中国中医急症, 2024, 33(8): 1474-1476.
[20] 彭思敏, 赵媚, 许光兰, 等. 基于现代医案挖掘中医药治疗慢性阻塞性肺疾病的证治规律[J]. 中国实验方剂学杂志, 2022, 28(15): 173-182.
[21] 文思敏, 范玉琴, 朱建平, 等. 名中医张震从虚、痰、瘀辨治慢性阻塞性肺疾病经验[J]. 陕西中医, 2024, 45(4): 532-535, 540.
[22] 张玉龙, 刘震东, 姚小青, 等. 杨仁旭教授辨治肺胀经验[J]. 四川中医, 2024, 42(4): 1-3.
[23] 张晓莉. 补肺健脾益肾方辅治慢性阻塞性肺疾病临床观察[J]. 实用中医药杂志, 2023, 39(10): 1985-1987.
[24] 秦超, 牟方政, 魏大荣. 骆常义主任中医师治疗肺胀用药规律分析[J]. 河北中医, 2023, 45(6): 896-899, 903.
[25] 杨彩云, 李卫, 曹敏. 开四关联合长蛇灸治疗慢性阻塞性肺疾病稳定期临床观察[J]. 中国中医药现代远程教育, 2023, 21(16): 100-102.
[26] 覃光辉. 六孔灸盒灸法治疗慢性阻塞性肺疾病急性加重期临床研究[J]. 中国中医药现代远程教育, 2024, 22(8): 118-121.
[27] 雷小婷, 赵润杨. 中药硬膏贴敷治疗慢阻肺合并肺炎临床观察[J]. 光明中医, 2024, 39(3): 499-502.
[28] 施墙微, 曾雅玲, 周佳. 穴位敷贴联合耳穴埋籽对肺胀病人临床症状及肺功能的影响[J]. 全科护理, 2023, 21(18): 2532-2534.
[29] 李楠. 八段锦干预慢性阻塞性肺疾病稳定期的研究进展[J]. 中国民间疗法, 2023, 31(15): 121-125.